VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for issue of Duplicate Share Certificate.17-05-2023
17-05-2023
VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 29Th May 2023.
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 29th May 2023 inter alia: 1. To consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March 2023. 2. Any other business with the permission of Chair.17-05-2023
VENUS REMEDIES LTD. - 526953 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In compliance of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Annual Secretarial Compliance Report of the Company for the year ended on 31st March 2023.16-05-2023
VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
VENUS REMEDIES LIMITED (VRL) RECOGNIZED FOR ITS IN-HOUSE R&D EXCELLENCE BY THE DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH (DSIR).16-05-2023
VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- Venus Remedies secures Marketing Authorization from UK MHRA for Cisplatin.25-04-2023
VENUS REMEDIES LTD. - 526953 - Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended on March 2023.15-04-2023
VENUS REMEDIES LTD. - 526953 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyVENUS REMEDIES LTD. 2CIN NO.L24232CH1989PLC009705 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Neha Arora Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Pawan Chaudhary Designation: Chief Financial Officer EmailId: [email protected] Date: 11/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.11-04-2023
VENUS REMEDIES LTD. - 526953 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Period Ended On 31St March 2023.
Compliance certificate under regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period ended on 31st March 2023.11-04-2023
VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance under Regulation74(5) of SEBI (Depositories and Participants) Regulations.2018.11-04-2023
VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Pravindra Singh Chauhan (DIN: 08068504), an Independent Director of our company, has submitted his resignation vide letter dated 4th April 2023. He has resigned from the Board of the Company with immediate effect, citing the time constraints as the reason for his resignation04-04-2023